Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous erythropoietin to reduce blood transfusion in SICU trauma patients
IRCT20250621066213N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of erythropoietin in psychological trauma and anaemia, sponsored by Yasouj University of Medical Sciences. Primary endpoint: Requirement for blood transfusion. Started Jul 2025; status: completed.
02
Drugs
erythropoietin
03
Conditions
psychological traumaanaemia
Beyond the preview
Go deeper on IRCT20250621066213N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250621066213N1.